La bourse ferme dans 8 h 14 min

ICON Public Limited Company (ICLR)

NasdaqGS - NasdaqGS Cours en temps réel. Devise en USD
Ajouter à la liste dynamique
301,07-0,54 (-0,18 %)
À la clôture : 04:00PM EDT
301,07 0,00 (0,00 %)
Échanges après Bourse : 04:00PM EDT

ICON Public Limited Company

South County Business Park
Leopardstown
Dublin D18 X5R3
Ireland
353 1 291 2000
https://www.iconplc.com

Secteur(s)Healthcare
Secteur d’activitéDiagnostics & Research
Employés à temps plein41 150

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Dr. John Climax Ph.D.Founder & Independent Non-Executive Director90kS.O.1953
Mr. Brendan BrennanChief Financial Officer1,07MS.O.1979
Dr. Steven A. Cutler MBA, Ph.D.CEO & Director2,54MS.O.1960
Jonathan Andrew CurtainSenior Vice President of Corporate & Commercial FinanceS.O.S.O.1976
Mr. Thomas N. O'LearyChief Information OfficerS.O.S.O.S.O.
Mr. Diarmaid CunninghamChief Administrative Officer, General Counsel & Company SecretaryS.O.S.O.1975
Ms. Niamh MurphyDirector of Corporate CommunicationsS.O.S.O.S.O.
Mr. David GreenVice President of MarketingS.O.S.O.S.O.
Mr. Joe CroninChief Human Resources OfficerS.O.S.O.S.O.
Mr. Simon HolmesPresident of Corporate Investments & PartnershipsS.O.S.O.1967
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also offers clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company provides laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, it offers adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. The company serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. ICON Public Limited Company was incorporated in 1990 and is headquartered in Dublin, Ireland.

Gouvernance d’entreprise

L’ISS Governance QualityScore de ICON Public Limited Company en date du S.O. est S.O.. Les scores principaux sont Audit : S.O.; Société : S.O.; Droits des actionnaires : S.O.; Compensation : S.O..

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.